METASTATIC PANCREATIC ADENOCARCINOMA
Clinical trials for METASTATIC PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune booster shows promise in tough pancreatic cancer trial
Disease control CompletedThis study tested an experimental immune-boosting drug called indoximod alongside standard chemotherapy for people with metastatic pancreatic cancer. The goal was to find the safest dose and see if the combination could help patients live longer. 157 adults with advanced pancreat…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: NewLink Genetics Corporation • Aim: Disease control
Last updated May 17, 2026 03:24 UTC
-
New drug cocktail shows promise for tough pancreatic cancer
Disease control CompletedThis study tested a combination of two drugs, LEE011 and everolimus, in 12 people with advanced pancreatic cancer that had stopped responding to standard chemotherapy. The goal was to find the best dose and see if the combo could slow cancer growth. The approach aims to control t…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New combo tackles tough pancreatic cancer in early trial
Disease control CompletedThis early-phase trial tested two drugs—binimetinib and hydroxychloroquine—in 34 people with advanced pancreatic cancer that has a KRAS gene mutation. The goal was to find the safest dose and see if the combination could slow tumor growth. Participants had already tried at least …
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New combo shows promise for tough pancreatic cancer
Disease control CompletedThis study tested whether a combination of two chemotherapy drugs (gemcitabine and paclitaxel) helps people with advanced pancreatic cancer live longer compared to gemcitabine alone. The 211 participants had already tried and failed or couldn't tolerate the standard first treatme…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Vitamin d and malaria drug join forces against pancreatic cancer
Disease control CompletedThis study tested whether adding two drugs—paricalcitol (a form of vitamin D) and hydroxychloroquine (an anti-malaria drug)—to standard chemotherapy could help people with advanced pancreatic cancer that has spread. Ten participants received the combination. The goal was to see i…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New cocktail targets tough pancreatic cancer
Disease control CompletedThis study tested a combination of three drugs (gemcitabine, trastuzumab, and erlotinib) as a first treatment for people with metastatic pancreatic cancer that has spread. The goal was to see if this mix could control the disease better. 63 patients took part, receiving the drugs…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New hope for tough pancreatic cancer: immunotherapy combo trial shows promise
Disease control CompletedThis early-phase trial tested combinations of immunotherapy drugs with standard chemotherapy in 45 people whose pancreatic cancer had spread. The goal was to see if these combos are safe and help shrink tumors. While not a cure, the study aims to improve disease control for this …
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Cancer Insight, LLC • Aim: Disease control
Last updated May 05, 2026 11:53 UTC
-
Weight loss drug shows promise for pancreatic cancer patients
Symptom relief CompletedThis study tested a drug called telotristat ethyl in 23 people with advanced pancreatic cancer who had lost at least 10% of their body weight. The goal was to see if the drug could help them stabilize or gain weight by reducing bowel movements. Maintaining weight may help patient…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated May 17, 2026 03:24 UTC